Patent · US Active

Monomaleimide-functionalized platinum compounds for cancer therapy

US11572379B2 · kind B2 · utility

0Cited by

2References

27Claims

0Family size

Assignees

Medizinische Universität Wien · AT
UNIVERSITÄT WIEN · AT

Inventors

Christian Kowol · Wien, AT
Petra Heffeter · Wien, AT
Walter Berger · Wien, AT
Bernhard Keppler · Heidelberg, DE
Josef Mayr · Wien, AT
Verena Pichler · Wien, AT

Key dates

Filing date	Jun 17, 2020
Grant date	Feb 7, 2023
Priority date	—
Expiry date	Jul 2, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel monomaleimide-functionalized platinum compounds of formula (I), including in particular novel monomaleimide-functionalized oxaliplatin and carboplatin derivatives, as well as their use as medicaments, particularly for the treatment or prevention of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.